Inactive Ingredient Disclosure Expansion In House User Fee Bill Poised For Changes

 
• By Derrick Gingery
  
Fred Upton discusses House user fee bill
Rep. Fred Upton, R-MI, debates the inactive ingredient provision in the House user fee reauthorization bill. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics